How oncologists can ethically navigate the 'Right-To-Try' drug law
How oncologists can ethically navigate the 'Right-To-Try' drug law
Only time will tell if 'Right to Try' is breakthrough or aberration - expanded Access appears to be successful. Only two patients so far, one cancer, one amyotrophic lateral sclerosis.